Expression of P-gp, MRP, LRP, GST-π and TopoIIα and Acquired Resistance to Cisplatin in Human Lung Adenocarcinoma Cells

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 2, 2011-02 ,pp. : 148-153

Bentham Science Publishers

Access to resources Recommend Favorite

The MEK1/2 inhibitor U0126 reverses imatinib resistance through down-regulating activation of Lyn/ERK signaling pathway in imatinib–resistant K562R leukemia cells

By Shi R.   Lin J.   Guo Y.   Gong Y.P.  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 5, 2014-05 ,pp. : 346-352

Govi-Verlag

Access to resources Recommend Favorite

The Role of STAT3 Signaling in Mediating Tumor Resistance to Cancer Therapy

By  

Current Drug Targets, Vol. 15, Iss. 14, 2014-12 ,pp. : 1341-1353

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of the novel DNA dependent protein kinase inhibitor, IC486241, on the DNA damage response to doxorubicin and cisplatin in breast cancer cells

By Davidson David  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1736-1742

Springer Publishing Company

Access to resources Recommend Favorite

Dual inhibition of MEK1/2 and EGFR synergistically induces caspase-3-dependent apoptosis in EGFR inhibitor-resistant lung cancer cells via BIM upregulation

By Song Ji-Young   Kim Choung-Soo   Lee Je-Hwan   Jang Se   Lee Sang-wook   Hwang Jung   Lim Chulsoo   Lee Gilnam   Seo Jeongbeob   Cho Suk   Choi Jene  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1458-1465

Springer Publishing Company

Access to resources Recommend Favorite